27,531 Shares in Merit Medical Systems, Inc. $MMSI Bought by Jupiter Topco LLC

Key Points

• Jupiter Topco LLC bought 27,531 shares of Merit Medical Systems worth approximately $1.9 million during the second quarter. Institutional investors and hedge funds now own 99.66% of the company.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $100, compared with the stock’s reported price of $88.57.
• Merit Medical exceeded quarterly expectations, reporting $1.19 in EPS versus the $0.96 consensus estimate and $418.84 million in revenue, up 9.5% year over year.

Jupiter Topco LLC bought a new position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 27,531 shares of the medical instruments supplier's stock, valued at approximately $1,908,000.

Several other hedge funds have also recently bought and sold shares of the business. J. Goldman & Co LP acquired a new stake in shares of Merit Medical Systems in the second quarter worth about $16,835,000. Hsbc Holdings PLC acquired a new position in shares of Merit Medical Systems during the 2nd quarter valued at about $414,000. Canada Pension Plan Investment Board bought a new position in shares of Merit Medical Systems in the 2nd quarter valued at approximately $388,000. Legal & General Group Plc bought a new position in shares of Merit Medical Systems in the 2nd quarter valued at approximately $9,472,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in Merit Medical Systems in the 2nd quarter worth approximately $33,591,000. 99.66% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on MMSI shares. Barrington Research set a $114.00 target price on Merit Medical Systems in a research report on Friday, July 31st. BTIG Research reissued a "buy" rating and issued a $105.00 price target on shares of Merit Medical Systems in a research report on Tuesday, August 11th. Wells Fargo & Company boosted their price objective on shares of Merit Medical Systems from $74.00 to $83.00 and gave the stock an "equal weight" rating in a research note on Friday, July 31st. Weiss Ratings raised shares of Merit Medical Systems from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, August 18th. Finally, Robert W. Baird set a $98.00 target price on shares of Merit Medical Systems in a research note on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $100.00.

Merit Medical Systems Price Performance

NASDAQ MMSI opened at $88.57 on Friday. The stock has a 50-day simple moving average of $81.49 and a 200 day simple moving average of $73.11. Merit Medical Systems, Inc. has a twelve month low of $59.74 and a twelve month high of $94.75. The stock has a market capitalization of $5.29 billion, a PE ratio of 36.60, a P/E/G ratio of 2.25 and a beta of 0.49. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last released its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.23. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The firm had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. During the same quarter last year, the firm posted $1.01 EPS. The company's revenue was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Research analysts anticipate that Merit Medical Systems, Inc. will post 3.84 EPS for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source